Atara Biotherapeutics, INC. (ATRA) — SC 13D/A Filings
All SC 13D/A filings from Atara Biotherapeutics, INC.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Adiumentum Capital Fund Amends Atara Biotherapeutics Stake
— Sep 5, 2024 Risk: medium
On September 5, 2024, Adiumentum Capital Fund I LP, formerly Adiumentum Capital Fund LP, filed an amendment (No. 1) to its Schedule 13D regarding Atara Biothera
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX